Moderna Soars On 'Transformational' Potential Of Its Cancer Vaccine
Moderna's (MRNA) Merck (MRK)-partnered cancer vaccine reduced the risk of relapse or death by 49% in melanoma patients, the companies said Thursday. The update fueled big gains for Moderna stock, which has been hamstrung recently on Covid news. The companies followed patients who received a…
#merck #keytruda #stephanebancel #rbccapitalmarkets #lucaissi #moderna #pfe #importantly #phase2 #rbc